YIH
AQST icon

Y-Intercept (HK)’s Aquestive Therapeutics AQST Stock Holding History

Y-Intercept (HK)’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-26,992
Closed -$112K – 1689
2026
Q1 		$112K Buy
+26,992
New +$110K ﹤0.01% 1461
2024
Q2 		– Sell
-16,592
Closed -$70.7K – 1373
2024
Q1 		$70.7K Sell
16,592
-6,980
-30% -$23.2K 0.01% 1295
2023
Q4 		$47.6K Buy
+23,572
New +$41.7K ﹤0.01% 1163

Other funds holding AQST

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
ACA
Adirondack Capital Advisors Syracuse, New York $186M AUM
CCM
Cox Capital Management Andover, Massachusetts $180M AUM 40.44% 1-Year Est. Return
LWA
Lineweaver Wealth Advisors Valley View, Ohio $845M AUM 20.71% 1-Year Est. Return
EC
Eleva Capital Paris, France $343M AUM
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
LF
LifeSteps Financial Claremont, California $215M AUM 27.52% 1-Year Est. Return

Y-Intercept (HK)'s AQST Position: Q2 2026 in Review

Y-Intercept (HK) sold out of Aquestive Therapeutics (AQST) in Q2 2026, closing a stake of 26,992 shares — an estimated $112K sold.

Y-Intercept (HK) first reported a position in AQST in Q4 2023 and held it in 3 quarters. The position peaked at $112K in Q1 2026. 11 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • Y-Intercept (HK) reported no remaining Aquestive Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 26,992 Aquestive Therapeutics shares in Q2 2026, an estimated $112K.
  • Y-Intercept (HK) first reported a position in Aquestive Therapeutics in Q4 2023 and held it in 3 quarters.
  • Y-Intercept (HK)'s Aquestive Therapeutics position peaked at $112K in Q1 2026.
  • 11 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.